Leuprolide Acetate for Puberty Suppression in Transgender and Gender Diverse Youth: A Comparison of Subcutaneous Eligard Versus Intramuscular Lupron

Year of Publication:

Categories of Publication:

Lay Abstract and Manuscript Citation:

Eitel KB, Hodax JK, DiVall S, Kidd KM, Salehi P, Sequeira GM. Leuprolide Acetate for Puberty Suppression in Transgender and Gender Diverse Youth: A Comparison of Subcutaneous Eligard Versus Intramuscular Lupron. J Adolesc Health. 2023 Feb;72(2):307-311. doi: 10.1016/j.jadohealth.2022.09.017. Epub 2022 Nov 18. PMID: 36404242

Find publication:

DOI: 10.1016/j.jadohealth.2022.09.017

The lay abstract for this publication was generated using an AI model and reviewed by the lead author and the PEDSnet Engagement Core team.

Scroll to Top